Avax Technologies Inc (AVXT)
0.00
USD |
OTCM |
Jun 28, 16:00
Avax Technologies 1 Year Total Returns (Daily)
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| January 29, 2024 | 0.00% |
| January 26, 2024 | 0.00% |
| January 25, 2024 | 0.00% |
| January 24, 2024 | 0.00% |
| January 23, 2024 | 0.00% |
| January 22, 2024 | 0.00% |
| January 19, 2024 | 0.00% |
| January 18, 2024 | 0.00% |
| January 17, 2024 | 0.00% |
| January 16, 2024 | 0.00% |
| January 12, 2024 | 0.00% |
| January 11, 2024 | 0.00% |
| January 10, 2024 | 0.00% |
| January 09, 2024 | 0.00% |
| January 08, 2024 | 0.00% |
| January 05, 2024 | 0.00% |
| January 04, 2024 | 0.00% |
| January 03, 2024 | 0.00% |
| January 02, 2024 | 0.00% |
| December 29, 2023 | 0.00% |
| December 28, 2023 | 0.00% |
| December 27, 2023 | 0.00% |
| December 26, 2023 | 0.00% |
| December 22, 2023 | 0.00% |
| December 21, 2023 | 0.00% |
| Date | Value |
|---|---|
| December 20, 2023 | 0.00% |
| December 19, 2023 | |
| December 18, 2023 | |
| December 15, 2023 | |
| December 14, 2023 | |
| December 13, 2023 | |
| December 12, 2023 | |
| December 11, 2023 | |
| December 08, 2023 | |
| December 07, 2023 | |
| December 06, 2023 | |
| December 05, 2023 | |
| December 04, 2023 | -99.00% |
| December 01, 2023 | -99.00% |
| November 24, 2023 | |
| November 22, 2023 | |
| November 21, 2023 | |
| November 20, 2023 | |
| November 17, 2023 | |
| November 16, 2023 | |
| November 15, 2023 | |
| November 14, 2023 | |
| November 13, 2023 | |
| November 10, 2023 | |
| November 09, 2023 |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-99.96%
Minimum
Jan 13 2022
9.90K%
Maximum
Dec 30 2022
154.2%
Average
--
Median
Jul 17 2019
1 Year Total Returns (Daily) Benchmarks
| AIM ImmunoTech Inc | -36.83% |
| Perspective Therapeutics Inc | 53.36% |
| Protalix BioTherapeutics Inc | -46.58% |
| Electromed Inc | 38.14% |
| Armata Pharmaceuticals Inc | 121.8% |